Webinars - Neurology
Presentation On-Demand | September 11, 2020
In this presentation, developed for MSVirtual2020 (ACTRIMS-ECTRIMS Joint Virtual Meeting), Dr. Sharel Figueredo explains how Simoa enables precise measurements of protein biomarkers in blood and CSF, even when biomarker concentration is low.
Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration
neurobiology of disease | October 25, 2019
Höglund K, Schussler N, Kvartsberg H, Smailovic U, Brinkmalm G, Liman V, Becker B, Zetterberg H, Cedazo-Minguez A, Janelidze S, Lefevre IA, Eyquem S, Hansson O and Blennow K. Neurobiol Dis. 2019 Oct 25;134:104645.
Cheryl Wellington, PhD from the University of British Columbia, presented on the functional modeling of the human cerebrovasculature at the inaugural Powering Precision Health Summit 2016.
Hosted by Cambridge Healthtech Institute
Hosted by Cambridge Healthtech Institute, this webinar will describe how blood biomarkers can be used to detect CNS disorders.
Predicting progression of neurodegeneration with a blood test: How neurofilament light protein may be a game-changer for therapeutic development in Huntington’s Disease
In this seminar, we will discuss the particularly striking results from our recent study of NfL in Huntington's disease and why we think it has real potential to change the course of therapeutic development in HD and other neurogenerative diseases.
Miriam Moscovitch-Lopatin, from MassGeneral Institute for Neurodegenerative Disease presented a longitudinal pre-cell biomarker study she conducted on an ultrasensitive Simoa immunoassay for quantifying BDNF levels in cerebral spinal fluid in early Huntington's disease at the inaugural Powering P